Coxsackievirus And Adenovirus Receptor
The coxsackievirus and adenovirus receptor (CAR) is a cell surface protein that plays a critical role in cell adhesion and is a primary entry point for several viruses, including coxsackieviruses and adenoviruses. Discovered for its function in mediating viral entry, CAR has since been recognized for its broader biological significance in normal physiological processes and various disease states.
Biological Basis
CAR is a transmembrane protein belonging to the immunoglobulin superfamily. It is characterized by two extracellular immunoglobulin-like domains, a transmembrane domain, and an intracellular C-terminal domain. Biologically, CAR is highly expressed in various tissues, particularly in the heart, brain, and pancreas, and is a component of tight junctions between epithelial and endothelial cells. Its role in cell-cell adhesion is crucial for maintaining tissue integrity and regulating paracellular permeability. Beyond its structural role, CAR also participates in cell signaling pathways. Its dual function as an adhesion molecule and a viral receptor highlights its complex involvement in cellular biology.
Clinical Relevance
The most prominent clinical relevance of CAR stems from its function as a receptor for several important human pathogens. It serves as the primary receptor for group B coxsackieviruses, which can cause diseases such as myocarditis (inflammation of the heart muscle), pancreatitis, and aseptic meningitis. Additionally, CAR is utilized by many serotypes of adenoviruses, commonly responsible for respiratory infections, conjunctivitis, and gastroenteritis. Understanding the interaction between these viruses and CAR is vital for developing antiviral therapies and vaccines. Beyond infectious diseases, altered CAR expression has been implicated in various cancers, where it can influence tumor growth, metastasis, and the efficacy of oncolytic adenovirus-based cancer therapies. Its expression levels and localization can also impact the pathogenesis of autoimmune conditions and inflammatory responses.
Social Importance
The study of CAR carries significant social importance due to its role in public health. As a key mediator of common viral infections, research into CAR contributes to our understanding of how these pathogens spread and cause disease, enabling the development of better diagnostic tools and preventive measures. Furthermore, CAR's involvement in gene therapy, particularly in enhancing the delivery of adenoviral vectors to target cells, holds promise for treating genetic disorders and cancers. By manipulating CAR expression or modifying viral vectors, scientists aim to improve the specificity and efficacy of these therapeutic approaches, ultimately impacting patient outcomes and quality of life. The multifaceted nature of CAR makes it a crucial target for both basic scientific inquiry and translational medicine.
Methodological and Statistical Constraints
Genome-wide association studies, while powerful, are subject to several methodological and statistical constraints that can influence the interpretation and generalizability of their findings. The sample sizes in many studies, even those considered large (e.g., 5,974 participants for uric acid analyses [1] ), may still lack sufficient statistical power to detect genetic variants with modest effect sizes, particularly after stringent correction for multiple testing. [2]
Replication of genetic associations is a critical step, yet it can be hampered by differences in study design, statistical power, and the specific genetic variants interrogated across studies. [3] Non-replication at the precise single nucleotide polymorphism (SNP) level does not necessarily negate a gene's involvement, as different SNPs within the same gene might be in strong linkage disequilibrium with an unobserved causal variant, or multiple causal variants could exist within a gene. [3] Additionally, the use of genotyping arrays with partial coverage of the genome, such as earlier 100K gene chips, can lead to an inability to fully capture genetic variation within candidate genes, thereby limiting the detection of novel associations or the replication of previously reported findings. [4]
Generalizability and Phenotype Measurement
A significant limitation in many genetic studies is the predominant focus on populations of European ancestry, such as cohorts primarily composed of Caucasians or individuals from founder populations. [1] While founder populations can offer advantages due to reduced genetic heterogeneity, findings from such groups may not be broadly applicable to other diverse ancestral populations. [3] Genetic architecture, including allele frequencies and linkage disequilibrium patterns, can vary considerably across different ancestries, meaning that associations identified in one population may not hold true or have the same effect size in another. This restricts the generalizability of results and underscores the need for more inclusive research populations.
The accurate and consistent measurement of phenotypes is also crucial, and variations or limitations in this aspect can impact study outcomes. For instance, while averaging phenotypic measurements across multiple examinations can reduce random error and improve statistical power, it might obscure temporal variability or specific acute effects that could be biologically relevant. [2] Moreover, to address the challenges of multiple testing, some studies may conduct sex-pooled analyses, which risk overlooking genetic variants that exert their effects in a sex-specific manner. [4] Such undetected sex-specific associations represent a gap in fully characterizing the genetic influences on traits, as the underlying biological mechanisms can often differ significantly between males and females.
Unaccounted Genetic and Environmental Factors
Despite the identification of numerous statistically significant genetic associations, a substantial portion of the heritability for many complex traits remains unexplained, a phenomenon often referred to as "missing heritability." Even strongly associated genetic variants may account for only a small fraction of the total phenotypic variance (e.g., 2.3% for certain biomarker concentrations or approximately 40% for serum-transferrin levels). [5] This suggests that a multitude of other genetic factors, including rare variants, structural variations like copy number variants, or complex epistatic interactions among genes, have yet to be discovered or fully characterized. [6] Furthermore, for many identified associations, the precise biological mechanisms through which these genetic variants influence the phenotype are often unknown, representing a fundamental knowledge gap.
Genetic effects are rarely independent of environmental contexts, and gene-environment (GxE) interactions play a critical role in shaping complex traits. However, many studies either do not extensively investigate these interactions or only explore a limited set of gene-environment pairings (e.g., three SNPs with five environmental factors). [1] Neglecting to account for these intricate interactions can lead to an incomplete understanding of disease etiology and phenotypic variability. Additionally, unmeasured or unadjusted environmental confounders can introduce bias, potentially obscuring true genetic signals or leading to spurious associations, thereby impacting the comprehensive and accurate interpretation of genetic findings. [2]
Variants
The genetic landscape influencing cellular functions and host-pathogen interactions is complex, with specific variants playing roles in cellular mechanics, metabolic pathways, and immune responses. Understanding these variants, particularly in relation to the coxsackievirus and adenovirus receptor (CXADR), provides insight into individual susceptibility to viral infections and related health traits. These genetic variations can alter how cells interact with their environment and pathogens, impacting overall health and disease outcomes.
The CXADR gene, encoding the coxsackievirus and adenovirus receptor, produces a protein crucial for cell adhesion and serves as the primary entry point for coxsackieviruses and many adenoviruses into human cells. Variants like rs571393204 in CXADR can potentially influence the structure or expression of this receptor, thereby affecting the efficiency of viral binding and the host's susceptibility to infection. [6] Such variations have significant implications, as they may determine individual differences in the likelihood or severity of diseases caused by these common viruses. Similarly, FUT2 (Fucosyltransferase 2) is involved in synthesizing H-antigens, which are secreted into bodily fluids and expressed on cell surfaces, influencing an individual's "secretor status". [5] The rs601338 variant in FUT2 is well-known for affecting susceptibility to various infections by altering the availability of specific carbohydrate structures that pathogens, including some viruses, recognize. While FUT2 does not directly bind CAR, its variants can indirectly impact general host defense mechanisms and the epithelial environment, potentially modulating overall viral vulnerability.
The SLC (Solute Carrier) gene family is vital for transporting diverse substances across cell membranes, impacting fundamental cellular processes and metabolism. SLC10A2 (Solute Carrier Family 10 Member 2), also known as ASBT, is primarily responsible for the reabsorption of bile acids in the intestine, a process critical for lipid digestion and cholesterol metabolism. [7] Variants such as rs56398830 and rs55971546 in SLC10A2, or rs7987433 (which involves SLC10A2 and LINC01309), could alter bile acid transport efficiency, potentially affecting gut health, immune responses, and the general cellular environment, thereby indirectly influencing viral susceptibility. SLC6A4 (Solute Carrier Family 6 Member 4), encoding the serotonin transporter, is crucial for regulating serotonin levels in the brain and periphery, influencing mood, gut motility, and immune function. [5] The variant rs12945042, located near SLC6A4 and SNORD63, could influence serotonin signaling, which has broad systemic effects that may indirectly modulate host responses to viral infections. Additionally, SLC51A (Solute Carrier Family 51 Member A) functions as an organic anion transporter, and its variant rs939885, located with PCYT1A, may affect the transport of various endogenous and exogenous compounds, influencing cellular detoxification and nutrient uptake pathways essential for maintaining cellular integrity against viral threats.
Other genes contribute to diverse cellular processes, and their variants can have broad implications for cell function and host defense. EXOC3L4 (Exocyst Complex Component 3-Like 4) is involved in the exocyst complex, which mediates vesicle trafficking and tethering to the plasma membrane, a fundamental process for cell secretion, growth, and proper membrane protein localization. [6] The rs2297066 variant in EXOC3L4 could affect these critical cellular transport mechanisms, potentially impacting the presentation of viral receptors or immune signaling molecules on the cell surface. MICAL3 (Microtubule-Associated Monooxygenase, Calponin and LIM Domain Containing 3) contributes to cytoskeletal dynamics and cell signaling, which are crucial for cell shape, migration, and the intricate processes of viral entry and replication. [5] The rs28434757 variant in MICAL3 might alter these cellular mechanics, influencing how cells respond to and internalize pathogens. PLEKHG1 (Pleckstrin Homology and RhoGEF Domain Containing G1) acts as a guanine nucleotide exchange factor for Rho GTPases, key regulators of the actin cytoskeleton and cell signaling pathways involved in immune responses and inflammation, where its rs4869689 variant could modulate these critical defense mechanisms. GPR39 (G Protein-Coupled Receptor 39) is a zinc-sensing receptor involved in various physiological processes, including metabolism and gastrointestinal function, and its rs6705147 variant might affect these systemic regulatory roles, indirectly influencing overall host health and resilience to viral challenges. Lastly, PCYT1A (Choline-Phosphate Cytidylyltransferase A), linked with rs939885 and SLC51A, is a rate-limiting enzyme in phosphatidylcholine synthesis, essential for cell membrane integrity and lipid signaling, which are critical components of the cellular machinery that viruses exploit for replication.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs601338 | FUT2 | gallstones matrix metalloproteinase 10 measurement FGF19/SCG2 protein level ratio in blood FAM3B/FGF19 protein level ratio in blood FAM3B/GPA33 protein level ratio in blood |
| rs571393204 | CXADR | coxsackievirus and adenovirus receptor measurement |
| rs56398830 rs55971546 |
SLC10A2 | gallstones level of tetraspanin-8 in blood cell surface A33 antigen measurement epithelial cell adhesion molecule measurement coxsackievirus and adenovirus receptor measurement |
| rs12945042 | SLC6A4 - SNORD63 | level of tetraspanin-8 in blood coxsackievirus and adenovirus receptor measurement taurochenodeoxycholic acid 3-sulfate measurement |
| rs2297066 | EXOC3L4 | alkaline phosphatase measurement serum gamma-glutamyl transferase measurement platelet volume platelet count level of tetraspanin-8 in blood |
| rs28434757 | MICAL3 | blood protein amount level of 2-hydroxyacid oxidase 1 in blood total blood protein measurement coxsackievirus and adenovirus receptor measurement 5'-nucleotidase measurement |
| rs4869689 | PLEKHG1 | coxsackievirus and adenovirus receptor measurement |
| rs6705147 | GPR39 | smoking initiation coxsackievirus and adenovirus receptor measurement |
| rs939885 | PCYT1A, SLC51A | level of tetraspanin-8 in blood cell surface A33 antigen measurement epithelial cell adhesion molecule measurement coxsackievirus and adenovirus receptor measurement level of organic solute transporter subunit beta in blood |
| rs7987433 | SLC10A2 - LINC01309 | level of tetraspanin-8 in blood cell surface A33 antigen measurement coxsackievirus and adenovirus receptor measurement level of organic solute transporter subunit beta in blood |
Biological Background
The provided research context does not contain specific information about the coxsackievirus and adenovirus receptor. Therefore, a biological background section cannot be generated based on the given materials.
References
[1] Dehghan, A. "Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study." Lancet, 2008.
[2] Vasan, R. S. "Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study." BMC Medical Genetics, 2007.
[3] Sabatti, C. "Genome-wide association analysis of metabolic traits in a birth cohort from a founder population." Nature Genetics, 2009.
[4] Yang, Q. "Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study." BMC Medical Genetics, 2007.
[5] Benjamin, E. J. "Genome-wide association with select biomarker traits in the Framingham Heart Study." BMC Med Genet, 2007.
[6] Melzer, D. "A genome-wide association study identifies protein quantitative trait loci (pQTLs)." PLoS Genet, 2008.
[7] Kathiresan, S. "Common variants at 30 loci contribute to polygenic dyslipidemia." Nat Genet, 2008.